Advanced search
Publication Cover
Renal Failure Volume 17, 1995 - Issue 5
Submit an article Journal homepage
6
Views
1
CrossRef citations to date
0
Altmetric
CLINICAL STUDY

Concentrating Capacity in Ifosfamide-Induced Severe Renal Dysfunction

Rainer RossiUniversity Children’s HospitalMünster, Germany
, MD,
Almut GöddeUniversity Children’s HospitalMünster, Germany
,
Almud KleinebrandUniversity Children’s HospitalMünster, Germany
,
Bettina RathUniversity Children’s HospitalMünster, Germany
, MD &
Herbert JürgensUniversity Children’s HospitalMünster, Germany
, MD
Pages 551-557 | Published online: 16 Nov 2020

REFERENCES

  • Suarez A, McDowell H, Niaudet P, Comoy E, Flamant F: Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology Report. J Clin Oncol 9:2177-2182, 1991.
  • Pratt CB, Meyer WH, Jenkins JJ, Avery L, McKay CP, Wyatt RJ, Hancock ML: Ifosfamide, Fanconi’s syndrome, and rickets. J Clin Oncol 9:1495-1499, 1991.
  • Brodehl J: The Fanconi’s syndrome. In Pediatric Kidney Disease (Edelman CM, ed). Boston: Little, Brown, 1992, pp 1841-1871.
  • Sangster G, Kaye SB, Caiman KC, Dalton JF: Failure of 2-mercaptoethane sulphonate sodium (MESNA) to protect against ifosfamide nephrotoxicity. Eur J Cancer Clin Oncol 20:435-436, 1983.
  • Smeitink J, Verreussel M, Schröder C, Lippens R: Nephrotoxicity associated with ifosfamide. Eur J Pediatr 148:164-166, 1988.
  • Beckwith C, Flaharty KK, Cheung AK. Beatty PG: Fanconi’s syndrome due to ifosfamide. Bone Marrow Transplant 11:71-73, 1993.
  • Skinner R, Pearson ADJ, Price L, Coulthard MG. Craft AW: Nephrotoxicity after ifosfamide. Arch Dis Child 65:732-738, 1990.
  • Ashraf MS, Brady J, Breatnach F, Deasy PF, O’Meara A: Ifosfamide nephrotoxicity in paediatric cancer patients. Eur J Pediatr 153:90-94, 1994.
  • Rossi R, Gödde A, Kleinebrand A, Riepenhausen M, Boos J, Ritter J, Jürgens H: Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients. J Clin Oncol 12:159-165, 1994.
  • Brodehl J, Gellissen K, Weber HP: Postnatal development of tubular phosphate reabsorption. Clin Nephrol 17:163-171, 1982.
  • Rossi R, Danzebrink S, Linnenbürger K, Hillebrand D, Griineberg M, Sablitzky V, Deufel Th, Ullrich K, Harms E: Assessment of tubular reabsorption of sodium, glucose, phosphate and amino acids based on spot urine samples. Acta Paediatr 83:1282-1286, 1994.
  • Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Ped Clin North Am 34:571-590, 1987.
  • Aronson AS, Svenningsen NW: DDAVP test for renal concentrating capacity in infants and children. Arch Dis Child 49:654-659, 1974.
  • Edelmann CM, Barnett HL. Troupkou V: A standardized test for renal concentrating capacity in infants and children. Am J Dis Child 114:639-644, 1967.
  • Chantier C, Barrait TM: Laboratory evaluation. In Pediatric Nephrology (Holliday, MA, Barratt TM, Vernier RL. eds), 2nd ed. Baltimore: Williams & Wilkins, 1985. pp 282-285.
  • Monnens L. Smulders Y, Lier H van, de Boo T: DDAVP Test for assessment of renal concentrating capacity in infants and children. Nephron 29:151-154, 1981.
  • Marild S. Jodal U, Jonasson G, Mangelus L, Odén A, Persson NG: Reference values for renal concentrating capacity in children by the desmopressin test. Pediatr Nephrol 6:254-257, 1992.
  • Houston IB, Boichis H, Edelmann CM Jr: Fanconi syndrome with renal sodium wasting and metabolic alkalosis. Am J Med 44:638-646, 1968.
  • Robillard JE. Smith FG, Smith FG Jr: Developmental aspects of renal function during fetal life. In Pediatric Kidney Disease (Edelmann CM, ed). Boston: Little, Brown, 1992. pp 3-19.
  • Walker RG: Lithium nephrotoxicity. Kidney Int suppl 42:S93-S98, 1993.
  • Willemse PHB, de Jong PE, Elema JD, Mulder NH: Severe renal failure following high-dose ifosfamide and mesna. Cancer Chemother Pharmacol 23:329-330, 1989.
  • Rossi R, Heimchen U, Schellong G: Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome—a report of two cases. Eur J Pediatr 151:384-387, 1992.
  • Bergeron M. Dubord L, Hausser C: Membrane permeability as a cause of transport defects in experimental Fanconi syndrome. J Clin Invest 57:1181-1189, 1976.
  • Mohrmann M. Ansorge S, Schmich U, Schönfeld B, Brandis M: Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture. Pediatr Nephrol 8:157-163, 1994.
  • Caron HN. Abeling N, van Gennip A, de Kraker J, Voute PA: Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimes. Med Pediatr Oncol 20:42-47. 1992.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.